StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) shareholders

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
15.4%
5M of 35M shares
Institutional holders
62
10 new, 7 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
21 buys · 0 sales
Net bought $521.77K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Amit Kumar6,173,09716.30%13D (active) amendmentJun 4, 2025
Michael Catelani2,468,1037.00%13D (active) amendmentJan 5, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ANIXValueChange% of portfolio
Vanguard Capital Management LLC1,329,8523.83%$3.72M+14,8700.00%
UBS Group AG585,4301.68%$1.64M+33,7930.00%
Laird Norton Trust Company, LLC578,7271.66%$1.62M+12,4000.03%
D.A. Davidson & Co.539,2721.55%$1.51M–0.01%
Geode Capital Management, LLC359,1941.03%$1.01M−5,5370.00%
Marshall Wace, Llp328,3320.94%$919.33K+155,1530.00%
BlackRock, Inc.199,7550.57%$559.31K+29,6520.00%
Vanguard Fiduciary Trust Co192,3560.55%$538.60K+1,2820.00%
State Street Corp159,0400.46%$445.31K–0.00%
Gsa Capital Partners Llp117,4650.34%$329.00K+18,6230.02%
LPL Financial LLC111,5350.32%$312.30K+30,5590.00%
Northern Trust Corp69,2350.20%$193.86K+2,4100.00%
Renaissance Technologies LLC59,3730.17%$166.24K−1,8000.00%
CoreCap Advisors, LLC52,0200.15%$145.66K–0.00%
Bank of New York Mellon Corp47,4420.14%$132.84K–0.00%
Westside Investment Management, Inc.43,0000.12%$120.40K−4,0000.02%
HighTower Advisors, LLC41,1500.12%$115.22K−4000.00%
Kestra Advisory Services, LLC38,0000.11%$106.40K−13,0000.00%
Corient Private Wealth LLC37,4000.11%$104.72K+17,4000.00%
Gemmer Asset Management LLC35,0000.10%$98.00K–0.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026625M15.4%10 / 167 / 70M0M
Q1 2026605M14.6%9 / 1510 / 172M1M
Q4 2025716M16.4%13 / 1913 / 81M1M
Q3 2025665M15.6%8 / 178 / 70M0M
Q2 2025665M15.4%12 / 1212 / 30M0M
Q1 2025586M16.1%8 / 108 / 70M0M
Q4 2024576M17.0%10 / 119 / 91M0M
Q3 2024586M16.2%10 / 913 / 40M0M
Q2 2024536M16.0%5 / 1210 / 101M1M
Q1 2024585M15.4%10 / 207 / 61M0M
Q4 2023554M12.8%11 / 1211 / 51M0M
Q3 2023494M11.3%7 / 615 / 31M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

12 funds held ANIX in Q2 2026, 80% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ANIXValue% of fundAs of
Vanguard Total Stock Market Index Fund936,9272.70%$2.62M0.00%Jun 30, 2026
Vanguard Extended Market Index Fund353,8781.02%$990.86K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund167,2620.48%$451.61K0.00%May 31, 2026
iShares Micro-Cap ETF107,4940.31%$300.98K0.02%Jun 30, 2026
Fidelity Total Market Index Fund52,6940.15%$142.27K0.00%May 31, 2026
Fidelity Series Total Market Index Fund46,6450.13%$125.94K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund24,1020.07%$65.08K0.00%May 31, 2026
Vanguard Institutional Total Stock Market Index Fund21,0790.06%$59.02K0.00%Jun 30, 2026
Vanguard Balanced Index Fund17,9680.05%$50.31K0.00%Jun 30, 2026
Schwab Total Stock Market Index Fund12,7850.04%$43.72K0.00%Jul 31, 2026
1290 VT Micro Cap Portfolio7,2050.02%$20.17K0.01%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Amit KumarChief Executive Officer, Director685,0001.97%Nov 2, 2026
Michael CatelaniPresident, COO, & CFO50,0000.14%Sep 30, 2026
Lewis H. Titterton jrDirector1,054,0033.03%Oct 26, 2026
Arnold M. BaskiesDirector140,5720.40%Sep 28, 2026
Emily GottschalkDirector45,6650.13%Jan 6, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Amit Kumar
Chief Executive Officer, Director
Oct 30, 2026Buy+5,000$3.17$15.85K685,000
Lewis H. Titterton jr
Director
Oct 23, 2026Buy+8,000$2.98$23.84K1,054,003
Amit Kumar
Chief Executive Officer, Director
Oct 22, 2026Buy+8,000$2.72$21.76K680,000
Michael Catelani
President, COO, & CFO
Sep 30, 2026Buy+5,500$2.84$15.62K50,000
Arnold M. Baskies
Director
Sep 24, 2026Buy+5,000$2.76$13.80K140,572
Amit Kumar
Chief Executive Officer, Director
Sep 24, 2026Buy+7,000$2.78$19.46K672,000
Lewis H. Titterton jr
Director
Sep 23, 2026Buy+49,036$2.69$131.91K1,046,003
Lewis H. Titterton jr
Director
Sep 10, 2026Buy+10,000$2.73$27.30K996,967
Amit Kumar
Chief Executive Officer, Director
Sep 10, 2026Buy+3,000$2.75$8.25K665,000
Amit Kumar
Chief Executive Officer, Director
Sep 10, 2026Buy+5,000$2.76$13.80K662,000
Amit Kumar
Chief Executive Officer, Director
Jul 31, 2026Buy+5,000$3.47$17.35K657,000
Arnold M. Baskies
Director
Jul 27, 2026Tax withholding−5,428$3.46$18.78K135,572
Arnold M. Baskies
Director
Jul 27, 2026Option exercise+6,000$3.13$18.78K141,000
Amit Kumar
Chief Executive Officer, Director
Jul 27, 2026Buy+5,000$3.44$17.20K652,000
Amit Kumar
Chief Executive Officer, Director
Jul 27, 2026Buy+3,188$3.37$10.74K647,000
Amit Kumar
Chief Executive Officer, Director
Jul 24, 2026Buy+3,000$3.73$11.19K643,812
Amit Kumar
Chief Executive Officer, Director
Jul 20, 2026Buy+5,000$3.46$17.30K640,812
Lewis H. Titterton jr
Director
Jul 20, 2026Buy+12,000$3.47$41.64K986,967
Lewis H. Titterton jr
Director
Jul 15, 2026Buy+2,797$3.28$9.17K974,967
Amit Kumar
Chief Executive Officer, Director
Jul 10, 2026Buy+5,000$3.04$15.20K635,812
Lewis H. Titterton jr
Director
Jun 16, 2026Buy+2,836$2.64$7.49K972,170
Amit Kumar
Chief Executive Officer, Director
Jun 12, 2026Buy+21,000$2.50$52.50K630,812
Arnold M. Baskies
Director
Jan 28, 2026Buy+10,000$3.04$30.40K135,000
Lewis H. Titterton jr
Director
Dec 15, 2025Option exercise+16,000$2.92$46.72K969,334
Amit Kumar
Chief Executive Officer
Oct 30, 2025Option exercise+200,000$2.92$584.00K779,925
Amit Kumar
Chief Executive Officer
Oct 30, 2025Tax withholding−169,439$4.06$687.92K610,486
Lewis H. Titterton jr
Director
Jul 31, 2025Buy+10,000$3.08$30.80K953,334
Amit Kumar
Chief Executive Officer
Jul 30, 2025Buy+5,000$3.16$15.80K579,925
Arnold M. Baskies
Director
Jul 18, 2025Buy+5,000$3.39$16.95K125,000
Lewis H. Titterton jr
Director
Jul 11, 2025Buy+10,000$3.14$31.40K943,334
Amit Kumar
Chief Executive Officer
Jul 11, 2025Buy+5,000$3.15$15.75K574,925
Amit Kumar
Chief Executive Officer
Jun 4, 2025Buy+10,000$2.85$28.50K569,925
Arnold M. Baskies
Director
Jan 28, 2025Buy+5,000$2.82$14.10K120,000
Lewis H. Titterton jr
Director
Jan 24, 2025Buy+1,000$3.00$3.00K933,334
Lewis H. Titterton jr
Director
Jan 23, 2025Buy+2,000$2.91$5.82K932,334
Lewis H. Titterton jr
Director
Jan 22, 2025Buy+2,000$3.01$6.02K930,334
Lewis H. Titterton jr
Director
Jan 21, 2025Buy+6,000$2.59$15.54K928,334
Lewis H. Titterton jr
Director
Jan 17, 2025Buy+10,000$2.57$25.70K922,334
Michael Catelani
President, COO, & CFO
Jan 15, 2025Buy+9,289$2.15$19.97K44,500
Amit Kumar
Chief Executive Officer
Jan 15, 2025Buy+43,000$2.23$95.89K559,925
Lewis H. Titterton jr
Director
Oct 22, 2024Option exercise+16,000$2.58$41.28K912,334
Lewis H. Titterton jr
Director
Jul 31, 2024Buy+5,580$3.23$18.02K896,334
Lewis H. Titterton jr
Director
Jul 30, 2024Buy+21,646$3.06$66.24K890,754
Lewis H. Titterton jr
Director
Jul 26, 2024Buy+7,700$3.03$23.33K869,108
Arnold M. Baskies
Director
Jul 26, 2024Buy+5,000$3.09$15.45K115,000
Lewis H. Titterton jr
Director
Jul 25, 2024Buy+796$2.81$2.24K861,408
Lewis H. Titterton jr
Director
Jun 14, 2024Buy+4,000$2.68$10.72K860,612
Lewis H. Titterton jr
Director
Jun 13, 2024Buy+405$2.70$1.09K856,612
Lewis H. Titterton jr
Director
Jun 11, 2024Buy+7,102$2.66$18.89K856,207
Lewis H. Titterton jr
Director
Jun 10, 2024Buy+330$2.60$858849,105
Lewis H. Titterton jr
Director
Jun 7, 2024Buy+10,738$2.52$27.06K848,775
Michael Catelani
President, COO, & CFO
Jun 7, 2024Buy+6,250$2.40$15.00K35,211
Amit Kumar
Chief Executive Officer
Jun 7, 2024Buy+25,000$2.41$60.25K516,925
Michael Catelani
President, COO, & CFO
Apr 30, 2024Award+1,189$2.52$3.00K28,961
Lewis H. Titterton jr
Director
Apr 9, 2024Buy+15,009$3.28$49.23K838,037
Amit Kumar
Chief Executive Officer
Mar 15, 2024Buy+30,000$3.22$96.60K491,925
Arnold M. Baskies
Director
Mar 15, 2024Buy+10,000$3.63$36.30K110,000
Michael Catelani
President, COO & CFO
Oct 31, 2023Award+1,117$2.69$3.00K27,772
Lewis H. Titterton jr
Director
Oct 10, 2023Option exercise+16,000$2.58$41.28K823,028
Amit Kumar
Chief Executive Officer, Director
Jul 31, 2023Sale−11,800$3.57$42.13K461,925

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
6.54%
2M shares short
Days to cover
8.4
At 0M shares a day
Change since last report
-2.0%
From 2M shares
Short volume, 20 days
51.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Anixa Biosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 53,772 shares on Aug 20, 2026 over the last 90 days.

See a number that looks wrong?